Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 24:22:100474.
doi: 10.1016/j.lrr.2024.100474. eCollection 2024.

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients

Jeffrey Baron  1 , Manu R Pandey  2 , Elizabeth A Griffiths  2 , Eunice S Wang  2
Affiliations

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients

Jeffrey Baron et al. Leuk Res Rep. .
No abstract available

Keywords: Growth factors; Jehovah's witness; Low-dose chemotherapy; Philadelphia chromosome positive acute lymphoblastic leukemia; Supportive care management; Tyrosine kinase inhibitors.

PubMed Disclaimer

Conflict of interest statement

Jeffrey Baron, none. Manu R. Pandey, none. Elizabeth A. Griffiths, Astex Pharmaceuticals – research support, Genentech Inc – research support, Blueprint Medicines Inc – research support, Celldex Therapeutics – research support, Bristol Myers Squibb/Celgene – research support & advisory board, Alexion Pharmaceuticals – research support, Apellis Pharmaceuticals – research support & advisory board, Abbvie Inc – advisory board, Alexion Inc/AstraZeneca Rare Disease – advisory board, CTI Biopharma – advisory board, Novartis – advisory board, Taiho Oncology – advisory board, Takeda Oncology – advisory board, Partner Therapeutics – advisory board, Dresner Foundation – advisory board, AAMDSIF – speaker, Medscape – speaker, ASH – speaker, S Karger Publishing – speaker, MediCom Worldwide – speaker, Physicians Educational Resource – speaker, Picnic Health – advisor, Artis Ventures – advisor, Via Pathways/Elsevier Inc – advisor, NCCN Guidelines – chair & member. Eunice S. Wang: Advisory board/consulting (Abbvie, Blueprint, Immunogen, Kite, Kura, Qiagen, Rigel, Schrodinger, Stemline, Syndax; Speaker role: Astellas, Pfizer, Dava Data monitoring committees: Abbvie, Gilead; Other: UpToDate.

Figures

Fig 1
Fig. 1
Clinical course including cytopenias, ALL directed therapy, supportive care, and responses in the first 60 days after diagnosis (A) Patient 1, (B) Patient 2.
See this image and copyright information in PMC

References

    1. Why don't Jehovah's witnesses accept blood transfusions? April 24, 2024, 2024. https://www.jw.org/en/jehovahs-witnesses/faq/jehovahs-witnesses-why-no-b....
    1. Muramoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses. BMJ. 2001;322(7277):37–39. doi: 10.1136/bmj.322.7277.37. Jan 6. - DOI - PMC - PubMed
    1. Haddad F.G., Sawyers J., Short N.J. Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Ther. Adv. Hematol. 2023;14:20406207231151294. doi:10.1177/20406207231151294. - DOI - PMC - PubMed
    1. Wieduwilt M.J., Yin J., Wetzler M., et al. A phase II study of Dasatinib and Dexamethasone as primary therapy followed by transplantation for adults with newly diagnosed Ph/BCR-ABL1-positive acute lymphoblastic leukemia (Ph+ ALL): final results of alliance/CALGB study 10701. Blood. 2018;132(Supplement 1) doi: 10.1182/blood-2018-99-120029. 309-309. - DOI
    1. Foa R., Vitale A., Vignetti M., et al. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2011;118(25):6521–6528. doi: 10.1182/blood-2011-05-351403. Dec 15. - DOI - PubMed

LinkOut - more resources